Amplyx Pharmaceuticals
Latest round
- Series C
Last raised
- May 2020
Total raised
- $135M
Investors
- 13
About Amplyx Pharmaceuticals
Founded in 2006 and based in California, US, Amplyx Pharmaceuticals, Inc. operates as a developer of small molecule drugs for the treatment of oncology and infectious diseases. The company was founded by Andre Marquis, Gerald Crabtree and Mitchell Mutz. In May 2020, Amplyx Pharmaceuticals, Inc. was acquired by Pfizer Inc. Amplyx Pharmaceuticals develops small molecule drugs with enhanced efficacy and lower toxicity by adding a second small molecule to an existing drug. Amplyx drug development pipeline has three product candidates under clinical development called fosmanogepix, APX2039 and MAU868. Fosmanogepix is a novel broad-spectrum antifungal agent being evaluated in Phase 2 clinical trials in patients with life-threatening fungal infections caused by aspergillosis and candidemia. MAU868 is a monoclonal antibody used for the treatment of clinically significant BK virus infection in people who have received either a kidney or hematopoietic cell transplant. The company’s future strategy includes advancing the clinical development of its product candidates.
Who invested in Amplyx Pharmaceuticals
13 investors across 4 rounds
See all investors in Amplyx Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Amplyx Pharmaceuticals
Who invested in Amplyx Pharmaceuticals?
Amplyx Pharmaceuticals has 13 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Amplyx Pharmaceuticals raised?
Amplyx Pharmaceuticals has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Amplyx Pharmaceuticals last raise money?
Amplyx Pharmaceuticals's most recent round on record is a Series C, in May 2020.
What does Amplyx Pharmaceuticals do?
Founded in 2006 and based in California, US, Amplyx Pharmaceuticals, Inc.
Where is Amplyx Pharmaceuticals headquartered?
Amplyx Pharmaceuticals is headquartered in San Diego, US.
Which VCs invest in companies like Amplyx Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Amplyx Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Amplyx Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.